Product Name |
MF |
CAS |
Details |
Ribociclib impurity-9 |
C12H12ClN3O |
1211443-55-8 |
|
8-Iodo-1,4-dioxaspiro[4.5]decane |
C8H13IO2 |
213833-68-2 |
|
Methyl 2-furoate |
C6H6O3 |
611-13-2 |
|
Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2- [(E,3R)-3-hydroxy-5-phenylpent-1- enyl]cyclopentyl]hept-5-enoate |
C26H38O5 |
130273-87-9 |
|
4-Piperidinopiperidine-1-carbonyl chloride |
C11H19ClN2O |
103816-19-9 |
|
DTT ( 1,4-dithiothreitol ) |
C4H10O2S2 |
578517 |
|
[4-(4-Ethylpiperazin-1-yl)phenyl]methano |
C13H20N2O |
402745-30-6 |
|
4-Nitrophenyl caprylate |
C14H19NO4 |
1956-10-1 |
|
1,2,3-TRICHLORO-5-NITROBENZENE |
C6H2Cl3NO2 |
20098-48-0 |
|
4-(oxetan-3-yl)pyridin-2-amine |
C8H10N2O |
1427501-89-0 |
|
Ribociclib impurity-6 |
C22H28N8O |
1211441-59-6 (free base) |
|
2-Bromo-1-(5-chloro-2-hydroxyphenyl)ethanone |
C8H6BrClO2 |
52727-99-8 |
|
(S)-2-(6-Hydroxy-2-naphthyl)propionic Acid |
C13H12O3 |
52079-10-4 |
|
(2R,3S)-5-[3-(tert-Butylamino)-2-hydroxypropoxy]- 1,2,3,4-tetrahydronaphthalene-2,3-diol |
C17H27NO4 |
42200-33-9 |
|
4-Ethylcatechol |
C8H10O2 |
1124-39-6 |
|
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester |
C21H27N2O7P |
1354823-36-1 |
|
6,6'-Dibromo-2,2'-bipyridyl |
C10H6Br2N2 |
49669-22-9 |
|
Methyl 3,5-dimethoxybenzoate |
C10H12O4 |
2150-37-0 |
|
imidazo[1,2-b]pyridazine |
C6H5N3 |
766-55-2 |
|
(R)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid |
C14H14O3 |
23979-41-1 |
|
3-Cyano-7-ethoxycoumarin |
C12H9NO3 |
117620-77-6 |
|
1-Methylindazole-3-carboxylic Acid |
C9H8N2O2 |
50890-83-0 |
|
N-Methyl-L-Phenylalanine |
C10H13NO2 |
2566-30-5 |
|
2-(3-Hydroxyphenyl)ethanol |
C8H10O2 |
13398-94-2 |
|
THIOPHEN-2-OL |
C4H4OS |
17236-58-7 |
|
2-Thioxoimidazolidin-4-one |
C3H4N2OS |
503-878-7 |
|
Methyl N 5-(2-methyl-4-oxopentan-2-yl)sulfanyl-1H- benzo[d]imidazol-2-ylcarbamate |
C15H19N3O3S |
2469260-71-5 |
|
Ribociclib impurity-7 |
C14H19N5O |
1331847-17-6 |
|
Iscotrizinol |
C44H59N7O5 |
154702-15-5 |
|
2-Bromo-3-methylacetophenone |
C9H9BrO |
51012-64-7 |
|
(2R,3R)-2,3-Dihydroxybutanedioic acid;2,2-diphenyl-2- [(3S)-pyrrolidin-3-yl]acetamide |
C22H26N2O7 |
134002-26-9 |
|
3-Amino-2,6-dichloro-benzaldehyde |
C7H5Cl2NO |
860725-31-1 |
|
2-Bromo-1-(4-methoxy-1,3-benzoxazol-2-yl)ethanone |
C10H8BrNO3 |
1806428-94-3 |
|
4-Amino-5-Bromo-2-chloropyridine |
C5H4BrClN2 |
857730-21-3 |
|
4-(3-Thioxo-3H-1,2-dithiol-4-yl)benzoic acid |
C10H6O2S3 |
1234567-87-3 |
|
2-BROMO-5-IODOTHIPPHENE |
C4H2BrIS |
29504-81-2 |
|
4-Methyl-1-phenylpentan-1-one |
C12H16O |
2050-07-9 |
|
4-NITROINDAN-1-ONE |
C9H7NO3 |
24623-25-4 |
|
(S)-Diethyl 2-(4-(methylamino)benzamido) pentanedioate |
C17H24N2O5 |
2378-95-2 |
|
Diglycolic acid |
C4H6O5 |
110-99-6 |
|
2-Chlorobenzoxazole |
C7H4ClNO |
615-18-9 |
|
3-Chloro-1,2-benzisothiazole |
C7H4ClNS |
7716-66-7 |
|
Niranthin |
C24H32O7 |
50656-77-4 |
|
2- Pyridine Methanol |
C6H7NO |
586-98-1 |
|
4 HYDROXYTHIOCOUMARIN |
C9H6O2S |
16854-67-4 |
|
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine Hydrochloride |
C13H20ClN |
312753-53-0 |
|
5’-Chloro-2’-hydroxy-4’-methylacetophenone |
C9H9ClO2 |
28480-70-8 |
|
5’-Chloro-2’-hydroxy-3’-nitroacetophenone |
C8H6ClNO4 |
84942-40-5 |
|
5-Bromo-2-(methylthio)pyrimidine-4-carboxylic acid |
C6H5BrN2O2S |
50593-92-5 |
|
sodium (S,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2- yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2- yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate |
C35H37ClNNaO3S |
190078-45-6 |
|
4-(Methylthio)benzoic Acid |
C8H8O2S |
13205-48-6 |
|
4-Phenylbutylamine |
C10H15N |
13214-66-9 |
|
2-(2-Methoxyphenoxy) ethanamine |
C9H13NO2 |
1836-62-0 |
|
Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
C14H18O3 |
19833-96-6 |
|
4-{2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl}benzenesulfonamide; Glimepiride EP Impurity B/USP Related Compound B |
C16H21N3O4S |
119018-29-0 |
|
Clopidogrel Metabolite H2 |
C16H18ClNO4S |
1415550-27-4 |
|
3-Methyl-2,4-pentanedione |
C6H10O2 |
815-57-6 |
|
2-Acetamido-5-amino pyridine |
C7H9N3O |
29958-14-3 |
|
1-Bromo-2-ethylbenzene |
C8H9Br |
1973-22-4 |
|
4-(4-Aminophenoxy)-N-methyl-2-pyridinecarboxamide (IP2014) |
C13H13N3O2 |
284462-37-9 |
|
L-proline methyl ester hydrochloride |
C6H12ClNO2 |
2133-40-6 |
|
2,4-Dichloro-6-fluoroquinoline |
C9H4Cl2FN |
406204-74-8 |
|
Epinephrine bitartrate S-isomer |
C13H19NO9 |
51-42-3 |
|
(R)-3-methylmorpholine |
C5H11NO |
74572-04-6 |
|
4-(4-(trifluoromethoxy)phenoxy) piperidine |
C12H14F3NO2 |
287952-67-4 |
|
2,3-Diamino-5-bromo pyridine |
C5H6BrN3 |
38875-53-5 |
|
3-BROMO-4-CHLOROANISOLE |
C7H6BrClO |
2732-80-1 |
|
Demethylwedelolactone |
C15H8O7 |
6468-55-9 |
|
furan-2-carboxylate |
C5H3O3- |
16053-89-7 |
|
Phosphonium, [3-[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxo-1,6-heptadien-1-yl]-2-methoxyphenoxy]propyl]triphenyl- (ACI) |
C42H40O6P |
1638920-66-7 |
|
Phosphonium, [3-[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxo-1,6-heptadien-1-yl]-2-methoxyphenoxy]propyl]triphenyl- (ACI) |
C42H40O6P |
1638920-66-7 |
|
1',4'-cis ABA Diol |
|
|
|
1',4'-cis ABA Diol |
|
|
|
2-chloro-4-((4S,5S)-4-((R)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile |
C14H12ClF3N2O3 |
1371608-50-2 |
|
2-chloro-4-((4S,5S)-4-((R)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile |
C14H12ClF3N2O3 |
1371608-50-2 |
|
Clopidogrel impurities and intermediates |
|
|
|
Clopidogrel impurities and intermediates |
|
|
|
Ketorolac intermediates, impurities and metabolites |
|
|
|
Ketorolac intermediates, impurities and metabolites |
|
|
|
2-(5-bromo-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethanol |
|
1897489-56-3 |
|
2-(5-bromo-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethanol |
|
1897489-56-3 |
|
1',4'-trans ABA Diol |
|
|
|
1',4'-trans ABA Diol |
|
|
|
4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a- phenyl-7a-(phenylcarbamoyl)hexahydro-3H- oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3- hydroxybutanoic acid |
|
873950-18-6 (acid); 1315629- 79-8 (Sodium Salt) |
|
4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a- phenyl-7a-(phenylcarbamoyl)hexahydro-3H- oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3- hydroxybutanoic acid |
|
873950-18-6 (acid); 1315629- 79-8 (Sodium Salt) |
|
Phosphonium, 1,1?-[[(1E,6E)-3,5-dioxo-1,6-heptadiene-1,7-diyl]bis[(2-methoxy-4,1-phenylene)oxy-3,1-propanediyl]]bis[1,1,1-triphenyl- (ACI) |
C63H60O6P2 |
1638920-65-6 |
|
Phosphonium, 1,1?-[[(1E,6E)-3,5-dioxo-1,6-heptadiene-1,7-diyl]bis[(2-methoxy-4,1-phenylene)oxy-3,1-propanediyl]]bis[1,1,1-triphenyl- (ACI) |
C63H60O6P2 |
1638920-65-6 |
|
(3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H- pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5- dihydroxy-heptanoic Acid |
|
887196-24-9 (salt) 887196-24-9 ( |
|
(3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H- pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5- dihydroxy-heptanoic Acid |
|
887196-24-9 (salt) 887196-24-9 ( |
|
3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5- dihydroxyheptanoic acid |
|
1428118-38-0 (Salt) 501121-34-2 (F |
|
3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5- dihydroxyheptanoic acid |
|
1428118-38-0 (Salt) 501121-34-2 (F |
|
(S)-3'-Bromoabscisic acid |
|
|
|
(S)-3'-Bromoabscisic acid |
|
|
|
Ribociclib impurity-2 (N-Boc Ribociclib) |
|
|
|
Ribociclib impurity-2 (N-Boc Ribociclib) |
|
|
|
(11E)-11-[3-(Dimethyl amino)propylidene]-6,11- dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride |
|
949141-22-4 (Salt) 113806-06-7 |
|
(11E)-11-[3-(Dimethyl amino)propylidene]-6,11- dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride |
|
949141-22-4 (Salt) 113806-06-7 |
|
2-chloro-4-((4S,5S)-4-((S)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile |
C14H12ClF3N2O3 |
1371608-49-9 |
|
2-chloro-4-((4S,5S)-4-((S)-2,2,2-trifluoro-1-hydroxyethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile |
C14H12ClF3N2O3 |
1371608-49-9 |
|
(S)-3'-Iodoabscisic acid |
|
|
|